Polomar Health Services, Inc. (PMHS)

Market Cap	2.24M
Revenue (ttm)	1.65M +3,214.6%
Net Income	-10.27M
EPS	-0.37
Shares Out	28.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	0.0526
Previous Close	0.0800
Day's Range	0.0526 - 0.0800
52-Week Range	0.0526 - 0.7999
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About Polomar Health Services

Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2023
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMHS

Financial Performance

In 2025, Polomar Health Services's revenue was $648,231, an increase of 1001.98% compared to the previous year's $58,824. Losses were -$10.70 million, 697.8% more than in 2024.